Prevalence of Airflow Obstruction in Nonsmoking Older Individuals Using Different Spirometric Criteria: The AGES Reykjavik Study

References

• Global Strategy for Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. 2008 [cited; 2012] Available from: www.goldcopd.org
   Google Scholar
• Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, Van WC, Zielinski J. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176:532–555.
   PubMed Web of Science ®Google Scholar
• Halbert RJ, Isonaka S, George D, Interpreting COPD prevalence estimates: What is the true burden of disease? Chest 2003; May 123(5):1684–1692.
   PubMed Web of Science ®Google Scholar
• Pauwels RA, Buist AS, Caverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management ant prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop Summary. Am J Respir Crit Care 2001; 163:1256–1273.
   PubMedGoogle Scholar
• Enright PL, Kronmal RA, Higgins M, Schenker M, Haponik EF. Spirometry reference values for women and men 65 to 85 years of age: Cardiovascular health study. Am Rev Respir Dis 1993; 147:125–133.
   PubMed Web of Science ®Google Scholar
• Schermer TRJ, Smeele IJM, Thoonen BPA, Lucas AEM, Grootens JG, van Boxem TJ, Heijdra YF, van Weel C. Current clinical guideline definitions of airflow obstruction and COPD overdiagnosis in primary care. Eur Respir J 2008; 32:945–952.
   PubMed Web of Science ®Google Scholar
• Hardie JA, Buist AS, Vollmer WM, Ellingsen O, Bakke PS, Mørkve O. Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J 2002; 20:1117–1122.
   PubMed Web of Science ®Google Scholar
• Hnizdo E, Glindmeyer HW, Petsonk EL, Enright P, Buist AS. Case definitions for chronic obstructive pulmonary disease. COPD 2006; 3(2):95–100.
   PubMedGoogle Scholar
• Cerveri I, Corsico AG, Accordini S, Niniano R, Ansaldo E, Antó JM, Künzli N, Janson C, Sunyer J, Jarvis D, Svanes C, Gislason T, Heinrich J, Schouten JP, Wjst M, Burney P, de Marco R. Underestimation of airflow obstruction among young adults using FEV1/FVC< 70% as a fixed cut-off: A longitudinal evaluation of clinical and functional outcomes. Thorax 2008; 63(12):1031–1032.
   PubMed Web of Science ®Google Scholar
• Celli BR, MacNee W, Agusti A, Anzueto A, Berg B, Buist AS, Calverley PMA, Chavannes N, Dillard T, Fahy B, Fein A, Heffner J, Lareua S, Meek P, Martinez F, McNicholas W, Muris J, Austegard E, Pauwels R, Rennard S, Rossi A, Siafakas N, Tiep B, Vestbo J, Wouters E, ZuWallack R. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23:932–946.
   PubMed Web of Science ®Google Scholar
• Hosesein FAAM, Zanen P, Lammers JJW. Lower limit of normal or FEV1/FVC < 0.70 in diagnosing COPD: An evidence-based review. Respir Med 2011; 105:907–915.
   PubMed Web of Science ®Google Scholar
• Feary JR, Rodriques LC, Smith CJ, Hubbard RB, Gibson JE. Prevalence of major co-morbidities in subjects with COPD abd incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care. Thorax 2010; 65(11):956–962.
   PubMed Web of Science ®Google Scholar
• Harris TB, Launer LJ, Eiriksdottir G, Kjartansson O, Jonsson PV, Sigurdsson G, Thorgeirsson G, Aspelund T, Garcia E, Cotch MF, Hoffman HJ, Gudnason V. Age, Gene/environment susceptibility–Reykjavik Study: Multidisciplinary applied phenomics. Am J Epidemiol 2007; 165:1076–1087.
   PubMed Web of Science ®Google Scholar
• Sigurdsson E, Thorgeirsson G, Sigvaldason H, Sigfusson N. Prevalence of coronary heart disease in Icelandic Men 1968–1986. The Reykjavik study. Euro Heart J 1993; 14:584–591.
   PubMed Web of Science ®Google Scholar
• Chinn S, Gislason T, Aspelund T, Gudnason V. Optimum expression of adult lung function based on all-cause mortality: Results from the Reykjavik study. Respir Med 2007; 101(3):601–609.
   PubMed Web of Science ®Google Scholar
• Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Epidemiol 1999; 159:179–187.
   Web of Science ®Google Scholar
• Swanney M, Ruppel G, Enright P, Pedersen O, Crapo R, Miller M, Jensen R, Falaschetti E, Schouten J, Hankinson J, Stocks J, Quanjer P. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax 2008; 63(12):1046–1051.
   PubMed Web of Science ®Google Scholar
• Hansen JG, Pedersen L, Overvad K, Omland Ø, Jensen HK, Sørensen HT. The prevalence of Chronic Obstructive Pulmonary Disease among Danes aged 45–84 years: Population-based Study. COPD 2008; 5:347–352.
   PubMedGoogle Scholar
• Szanto O, Montnemery P, Elmstahl S. Prevalence of airway obstruction in the elderly: Results from a cross-sectional spirometric study of nine age cohorts between the ages of 60 and 93 years. Prim Care Respir J 2010; 19(3):231–236.
   PubMedGoogle Scholar
• Jing J, Huang T, Cui W, Xu F, Shen H. Should FEV1/FEV6 Replace FEV1/FVC ratio to detect airway obstruction? A metaanalysis. Chest 2009; 135(4):991–998.
   PubMed Web of Science ®Google Scholar
• Vollmer WM, Gislason Þ, Burney P, Enright PL, Gulsvik A, Kocabas A, Buist AS for the BOLD Collaborative Research Group. Comparison of spirometry criteria for the diagnosis of COPD: Results from the BOLD study. Eur Respir J 2009; 34:588–597.
   PubMed Web of Science ®Google Scholar
• Pellegrino R, Brusasco V, Viegi G, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson DC, MacIntyre N, McKay R, Miller MR, Navajas D, Pedersen OF, Wanger J. Definition of COPD: Based on evidence or opinion? Eur Respir J 2008; 31:681–682.
   PubMed Web of Science ®Google Scholar
• Schneider K, O'Donnell BE, Dean D. Prevalence of multiple chronic conditions in the United States’ Medicare population. Health Qual Life Outcomes 2009; 7:82.
   PubMed Web of Science ®Google Scholar
• Wolff JL, Starfield B, Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med 2002: 162: 2269–2276.
   PubMed Web of Science ®Google Scholar
• Barr RG, Celli BR, Mannino DM, Co-morbidities, patient knowledge, and disease management in a national sample of patients with chronic obstructive pulmonary disease. Am J Med 2009; 122:348–355.
   PubMed Web of Science ®Google Scholar
• Holguin F, Folch E, Redd SC, Mannino DM. Co-morbidity and mortality in COPD-related hospitalizations in the United States, 1979–2001. Chest 2005; 128:2005–2011.
   PubMed Web of Science ®Google Scholar
• Balasubramanian V, Varkey B. Chronic obstructive pulmonary disease: effects beyond the lungs. Curr Opin Pulm Med 2006; 12:106–112.
   PubMed Web of Science ®Google Scholar
• Wannamethee SG, Shaper AG, Whincup PH. Body fat distribution, body composition and respiratory function in elderly men. Am J Clin Nutr 2005; 82(5):996–1003.
   PubMed Web of Science ®Google Scholar
• Hazenkamp-von Arx ME, Götschi Fellmann T, Oglesby L, Ackerman-Liebrich U, Gislason T, Heinrich J, Jarvis D, Luczynska C, Mansanera AJ, Modig L, Norbäck D, Pfeifer A, Poll A, Ponzio M, Soon A, Vermeire P, Künzli N. European study centers of ECRHS II: Method and first winter results. J Air Waste Manag Assoc 2003; 53(5):617–628.
   PubMedGoogle Scholar
• Johannessen A, Omenaas ER, Bakke PS, Gulsvik A. Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: A community study. Thorax 2005; 60:842–847.
   PubMed Web of Science ®Google Scholar
• Bhatt NY, Wood KL. What defines abnormal lung function in older adults with chronic obstructive pulmonary disease? Drugs Aging 2008; 25(9):717–728.
   PubMed Web of Science ®Google Scholar